Who are Merck & Co.'s decision-makers?
Merck & Co. is led by Rob Davis. Sellers should map decisions across the executive sponsor, business-unit owner, procurement, legal, security, privacy, compliance, finance, clinical or scientific stakeholders, and implementation owners.
- CEO
- Rob Davis
- CFO/key exec
- Caroline Litchfield
- Founded
- 1891
- Employees
- 72,000+
- HQ
- Rahway, NJ
- Status
- NYSE: MRK
- Rob DavisChairman and Chief Executive OfficerCEO since 2021Leads Merck's next growth phase as Keytruda matures and new launches scale.
- Caroline LitchfieldChief Financial OfficerCFO since 2021Oversees finance, capital allocation, and investor planning.
- Dean Y. LiPresident, Merck Research LaboratoriesR&D leader since 2021Runs discovery, clinical development, and pipeline strategy.
- Joseph RomanelliPresident, Human Health InternationalSenior commercial leaderLeads international human-health commercialization.
Who leads Merck & Co.?
Merck & Co.'s leadership team combines enterprise healthcare operations, finance, R&D, clinical, product, technology, legal, manufacturing, and commercial roles. The CEO and CFO set capital priorities, while business-unit leaders decide which operational problems become funded initiatives.
Who actually makes buying decisions at Merck & Co.?
Buying decisions usually start with a business-unit sponsor, then move through procurement, finance, legal, information security, privacy, compliance, quality, and implementation owners. Clinical, reimbursement, regulatory, or scientific stakeholders become essential whenever the purchase touches patient care, regulated data, clinical evidence, medical products, lab workflows, or payer/provider economics.
How is Merck & Co. organized as it scales?
Merck & Co. operates through product, therapeutic-area, regional, manufacturing, commercial, and corporate functions. That creates multiple entry points, but enterprise standards for security, privacy, compliance, contracting, vendor risk, and data governance can still control the final approval path.
As of June 2026.Sources:Merck & Co. leadershipMerck & Co. annual reports
Merck & Co. — frequently asked questions
